Subscribe to access full data
Company Business Sector Market cap ($) # net buying insiders Net value bought ($) % of float bought % of shares held by insiders
Pharmaceuticals & Medical Research Mega (1.0tn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mega (653.5bn) -1–5 -$10M–$100M -0–15% 0–15%
US Abbvie Inc (ABBV)
Pharmaceuticals & Medical Research Mega (459.3bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (372.3bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Mega (333.3bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (313.6bn) 0 No activity — —
CH Novartis AG (NOVN)
Pharmaceuticals & Medical Research Mega (275.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (255.3bn) 1–5 $10M–$100M 0–15% 0–15%
Healthcare Services Mega (246.0bn) -1–5 -$10M–$100M -0–15% 0–15%
US Amgen Inc (AMGN)
Pharmaceuticals & Medical Research Mega (221.8bn) -1–5 -$1M–$10M -0–15% 0–15%
DK Novo Nordisk A/S (NOVO-B)
Pharmaceuticals & Medical Research Mega (201.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (189.3bn) 0 No activity — 0–15%
Healthcare Services Large (176.0bn) -1–5 -$10M–$100M -0–15% 0–15%
US Pfizer Inc (PFE)
Pharmaceuticals & Medical Research Large (162.6bn) 1–5 $1M–$10M 0–15% 0–15%
Healthcare Services Large (155.4bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (144.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (130.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (125.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (119.9bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (111.4bn) 0 No activity — 0–15%
Healthcare Services Large (107.4bn) 0 No activity — 0–15%
Healthcare Services Large (105.5bn) -1–5 -$100M+ -0–15% 0–15%
FR Sanofi SA (SAN)
Pharmaceuticals & Medical Research Large (104.9bn) 0 No activity — 0–15%
GB GSK plc (GSK)
Pharmaceuticals & Medical Research Large (99.8bn) 11–20 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (97.2bn) 0 No activity — 15–50%
AU CSL Ltd (CSL)
Pharmaceuticals & Medical Research Large (90.6bn) 0 No activity — 0–15%
Healthcare Services Large (87.3bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals & Medical Research Large (84.8bn) 0 No activity — 0–15%
US Moderna Inc (MRNA)
Pharmaceuticals & Medical Research Large (78.8bn) 0 No activity — 0–15%
US Celgene Corp (CELG)
Pharmaceuticals & Medical Research Large (77.0bn) 0 No activity — —
Healthcare Services Large (72.3bn) 0 No activity — 0–15%
Healthcare Services Large (65.1bn) 1–5 $1M–$10M 0–15% 0–15%
US Allergan plc (AGN)
Pharmaceuticals & Medical Research Large (63.7bn) 0 No activity — 0–15%
Healthcare Services Large (60.0bn) -1–5 -$1M–$10M -0–15% 0–15%
NL argenx SE (ARGX)
Pharmaceuticals & Medical Research Large (59.5bn) -6–10 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (57.0bn) 0 No activity — 0–15%
DE Bayer AG (BAYN)
Pharmaceuticals & Medical Research Large (55.1bn) 0 No activity — —
Pharmaceuticals & Medical Research Large (51.4bn) -6–10 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (51.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (51.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (50.1bn) -1–5 -$1M–$10M -0–15% 0–15%
BE Ucb SA (UCB)
Pharmaceuticals & Medical Research Large (49.4bn) 1–5 < $100K 0–15% 15–50%
Healthcare Services Large (48.7bn) -1–5 -< $100K -0–15% 0–15%
Healthcare Services Large (45.6bn) -1–5 -$100K–$1M -0–15% 0–15%
US Humana Inc (HUM)
Healthcare Services Large (45.6bn) 0 No activity — 0–15%
Healthcare Services Large (44.7bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Large (44.1bn) -6–10 -$10M–$100M -0–15% 0–15%
US Medline Inc (MDLN)
Healthcare Services Large (43.8bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Large (43.8bn) -1–5 -$1M–$10M -0–15% 0–15%
US Seagen Inc (SGEN)
Pharmaceuticals & Medical Research Large (43.2bn) 0 No activity — 0–15%
US Waters Corp (WAT)
Healthcare Services Large (42.6bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (41.1bn) -1–5 -$1M–$10M -0–15% 0–15%
GB Haleon PLC (HLN)
Pharmaceuticals & Medical Research Large (39.7bn) 1–5 < $100K 0–15% 0–15%
Pharmaceuticals & Medical Research Large (39.0bn) 0 No activity — 0–15%
US Illumina Inc (ILMN)
Healthcare Services Large (38.6bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Large (33.8bn) 0 No activity — 0–15%
US Resmed Inc (RMD)
Healthcare Services Large (33.4bn) 0 No activity — 0–15%
US Biogen Inc (BIIB)
Pharmaceuticals & Medical Research Large (33.3bn) -1–5 -$100K–$1M -0–15% 0–15%
US Dexcom Inc (DXCM)
Healthcare Services Large (32.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (32.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (32.0bn) 0 No activity — 50%+
Healthcare Services Large (31.9bn) 0 No activity — 0–15%
US Centene Corp (CNC)
Healthcare Services Large (31.3bn) -1–5 -$1M–$10M -0–15% 0–15%
CH Alcon AG (ALC)
Healthcare Services Large (30.8bn) 0 No activity — 0–15%
Healthcare Services Large (29.1bn) 1–5 < $100K 0–15% 15–50%
US Zoetis Inc (ZTS)
Pharmaceuticals & Medical Research Large (28.9bn) 0 No activity — 0–15%
US Cerner Corp (CERN)
Healthcare Services Large (27.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (27.6bn) -1–5 -$10M–$100M -0–15% 15–50%
Healthcare Services Large (26.8bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Large (26.7bn) -1–5 -$1M–$10M -0–15% 50%+
Pharmaceuticals & Medical Research Large (26.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (26.4bn) -1–5 -$10M–$100M -0–15% 0–15%
US Incyte Corp (INCY)
Pharmaceuticals & Medical Research Large (25.7bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (25.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (25.5bn) 0 No activity — 0–15%
DE Biontech SE (BNTX)
Pharmaceuticals & Medical Research Large (25.3bn) -1–5 -$10M–$100M -0–15% 50%+
Healthcare Services Large (25.3bn) -1–5 -$100K–$1M -0–15% 0–15%
US Steris Ltd (STE)
Healthcare Services Large (23.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (23.5bn) -6–10 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (23.2bn) 1–5 $100K–$1M 0–15% 15–50%
Pharmaceuticals & Medical Research Large (23.2bn) -1–5 -$100K–$1M -0–15% 0–15%
IE STERIS plc (STE)
Healthcare Services Large (23.2bn) -1–5 -$100K–$1M -0–15% 0–15%
DK Genmab A/S (GMAB)
Pharmaceuticals & Medical Research Large (21.9bn) 0 No activity — 0–15%
Healthcare Services Large (21.7bn) -11–20 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (20.3bn) 0 No activity — 0–15%
US Viatris Inc (VTRS)
Pharmaceuticals & Medical Research Large (20.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (20.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (19.4bn) 0 No activity — 50%+
Healthcare Services Large (18.4bn) 1–5 $100K–$1M 0–15% 15–50%
Healthcare Services Large (17.9bn) 0 No activity — 50%+
Healthcare Services Large (17.8bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Large (17.6bn) -6–10 -$100M+ -0–15% 15–50%
US ABIOMED Inc (ABMD)
Healthcare Services Large (17.2bn) 0 No activity — 0–15%
US Hologic Inc (HOLX)
Healthcare Services Large (16.9bn) 0 No activity — 0–15%
US Revvity, Inc. (RVTY)
Healthcare Services Large (16.9bn) 0 No activity — 0–15%
Healthcare Services Large (16.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (16.6bn) -6–10 -$10M–$100M -0–15% 0–15%
DE Sartorius AG (SRT)
Healthcare Services Large (16.1bn) 0 No activity — 50%+
IN Cipla Ltd (CIPLA)
Pharmaceuticals & Medical Research Large (15.9bn) 0 No activity — 15–50%
Healthcare Services Large (15.6bn) 0 No activity — 15–50%